Accessibility Menu
Teladoc Health logo

Teladoc Health

(NYSE) TDOC

Current Price$9.74
Market Cap$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-67%
5 Year-94%
1 Year+20%
1 Month+20%
Teladoc Health last closing stock price
MetricPriceDate
Last closeUSD 9.652026-07-20
Teladoc Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 9.652026-07-13
1 month+19.58%USD 8.072026-06-18
3 month+60.83%USD 6.002026-04-21
Year to date+37.86%USD 7.002025-12-31
1 year+19.88%USD 8.052025-07-18
3 year-58.92%USD 23.492023-07-21
5 year-93.71%USD 153.322021-07-21
Since inception-66.91%USD 28.502015-07-01

Teladoc Health Financials at a Glance

Market Cap

$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.51B

Net Income (TTM)

-$171.15M

EPS (TTM)

-$0.96

P/E Ratio

-10.02

Dividend

$0.00

Beta (Volatility)

1.71 (High)

Price

$9.74

Volume

32,338

Open

$9.50

Previous Close

$9.65

Daily Range

$9.49 - $9.85

52-Week Range

$4.40 - $9.89

Estimated Earnings Date

Jul 29, 2026

About Teladoc Health

Teladoc Health lets people see doctors through their phones or computers. It helps patients manage health needs and long-term illnesses from home. These services support employers, health plans, and individual users.

Connecting Patients with Providers

  • Integrated Care: Global virtual medical services including general care, specialty visits, and chronic condition management; segment revenue reached $395.4 million in Q1 2026.
  • BetterHelp: Mental health platform providing virtual therapy and wellness services directly to consumers; segment revenue contributed $218.4 million in Q1 2026.
  • Chronic Care Management: Specialized programs for long-term health issues like diabetes and hypertension; enrollment grew 4% year-over-year to 1.197 million enrollees in Q1 2026.

Acquisitions and Branding Shifts

  • Acquired Catapult Health on February 28, 2025, for $65.3 million to expand its integrated medical offerings.
  • Purchased Uplift Health Technologies, Inc. on April 30, 2025, for $29.6 million to strengthen mental health capabilities.
  • Bought Telecare Australia Pty Ltd on August 8, 2025, to grow its presence in international medical markets.
  • Started moving chronic condition services to the main Teladoc Health brand in late 2025 to simplify its market identity.

What Sets the Network Apart?

Teladoc Health connects care providers and patients through a specialized technology platform for personalized health management. The network delivers services across various clinical and mental health categories through professional medical associations. The company relocated its principal executive office to New York City in June 2025 to support its ongoing operations.

Performance in Early 2026

  • Revenue was $613.8 million in Q1 2026, down 2.5% from the $629.4 million reported in Q1 2025.
  • Net loss was $63.8 million in Q1 2026, which improved from the $93.0 million loss recorded in Q1 2025.
  • Operating cash flow reached $9.5 million for the three months ended March 31, 2026.
  • Average monthly revenue per U.S. member rose to $1.30 in Q1 2026, up from $1.27 a year earlier.

Evolution of Global Healthcare

Teladoc Health has transitioned from a basic telehealth provider into a comprehensive global platform for integrated virtual care. Its focus on merging medical services with chronic care and mental health supports its long-term market position.

AI Generated • May 1, 2026

Industry

Health Care Technology

Employees

5,600

CEO

Charles Divita, III, CPA

Headquarters

New York, NY 10577, US

TDOC Financials

Key Financial Metrics (TTM)

Gross Margin

65.62%

Operating Margin

-7.60%

Net Income Margin

-6.81%

Return on Equity

-12.37%

Return on Capital

-10.84%

Return on Assets

-6.10%

Earnings Yield

-9.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

180.51M

Volume

32.34K

Avg. Volume

4.71M

Financials (TTM)

Gross Profit

$1.65B

Operating Income

-$191.07M

EBITDA

$57.31M

Operating Cash Flow

$287.95M

Capital Expenditure

-$36.87M

Free Cash Flow

$251.09M

Cash & ST Invst.

$750.74M

Total Debt

$1.04B

Teladoc Health Performance Analysis

Teladoc Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,406,840,00018.4%
20232023-12-31USD 2,602,415,0008.1%
20242024-12-31USD 2,569,574,000-1.3%
20252025-12-31USD 2,529,977,000-1.5%
Teladoc Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-300.4%
Q32025-09-30-0.9%
Q42025-12-312.5%
Q12026-03-31-4.4%
Teladoc Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -84.602996.5%
20232023-12-31USD -1.34-98.4%
20242024-12-31USD -5.87338.4%
20252025-12-31USD -1.14-80.6%
Teladoc Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3064.2%
Q32025-09-30-47.4%
Q42025-12-3150.0%
Q12026-03-31-157.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$613.85M

-2.5%

Gross Profit

$324.03M

-25.1%

Gross Margin

52.79%

N/A

Market Cap

$1.74BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$311.06K

N/A

Employees

5,600

N/A

Net Income

-$63.84M

+31.4%

EBITDA

$38.71M

+531.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$750.74M

-37.1%

Total Debt

$1.04B

-34.6%

Accounts Receivable

$222.54M

-8.5%

Inventory

$31.56M

-17.0%

Long Term Debt

$1.03B

+0.1%

Short Term Debt

$10.50M

-98.1%

Return on Assets

-6.10%

N/A

Return on Invested Capital

-7.95%

N/A

Free Cash Flow

$7.86M

+150.1%

Operating Cash Flow

$9.52M

-40.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVCRNovocure Ltd
$16.21+1.69%
OMCLOmnicell, Inc.
$43.80-3.15%
IMNMImmunome, Inc.
$21.98-0.81%
OMDAOmada Health
$23.14-3.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
UTZUtz Brands
$14.08+0.89%
ONDSOndas
$7.64+0.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.42+0.07%
CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF
$6.15+0.23%

Questions About TDOC

What is the current price of Teladoc Health?

Teladoc Health is trading at $9.74 per share.

What is the 52-week range for Teladoc Health?

Over the past 52 weeks, Teladoc Health has traded between $4.40 and $9.89.

How much debt does Teladoc Health have?

As of the most recent reporting period, Teladoc Health reported total debt of $1.04B.

How much cash does Teladoc Health have on hand?

Teladoc Health reported $750.74M in cash and cash equivalents in its most recent financial results.

What is Teladoc Health’s dividend yield?

Teladoc Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.